Signaling & Tumor Microenvironment

Dr. Max Wicha talks to his laboratory assistant in front of a computer

Understanding how cellular pathways intersect to impact cancer

Intranet

The Signaling and Tumor Microenvironment Program has a long history as a leader in translational cancer research. Program co-leaders Marina Pasca di Magliano, PhD; Yatrik Shah, PhD; and Weiping Zou, MD, PhD have built a program with close ties to many clinical departments to expedite information exchange between the laboratory and the clinic. As such, program members are investigators on multi-investigator program grants from the National Institutes of Health.

Nationally Lauded Experts

Signaling and Tumor Microenvironment (STEM) team members are nationally lauded experts representing diverse disciplines and perspectives. In addition to their research, the faculty are dedicated to educating and training the next generation of cancer investigators and in making a difference in the lives of patients with cancer. The program includes studies on the following:

  • Angiogenesis
  • Apoptosis
  • Biomarkers
  • Cancer stem cells
  • Cell adhesion
  • Epithelial-to-mesenchymal transition
  • Gene expression
  • Immunotherapy
  • Invasion
  • Metastasis
  • Oncogenes
  • Resistance to therapy and tumor modeling
  • Signaling
  • Transcription
  • Tumor microenvironment
  • Tumor suppressor genes

Signaling and Tumor Microenvironment Program Specific Aims

Aim 1: Signaling
Elucidate the role of cell fate and plasticity during tissue homeostasis and cancer progression.

Aim 2: Microenvironment
Define the heterocellular interactions that drive tumor epithelial growth and treatment response.

Aim 3: Metabolic Pathways
Characterize metabolic and metabolite interactions that impact cancer growth and progression.

 

Unified Team Collaborates on Discoveries

The physician-scientists in the Signaling and Tumor Microenvironment Program are brought together through a variety of impactful programmatic efforts, collaborative activities, mentorship and resources. The highly skilled members are unified through the following areas:

  • Cell signaling changes occurring within tumor cells and the microenvironment that affect cancer growth
  • Stem cell and cancer stem cell biology
  • The role of the microenvironment in the development, progression and metastatic dissemination of cancer

Determination of Biological Vulnerabilities

One of the key aims of the Signaling and Tumor Microenvironment Program is to define the biological behavior and signaling properties of cancer stem cells as they relate to tumor progression and treatment.

By understanding the cellular foundation of a cancer or tumor mass and the differences in cancer stem cells as compared to normal stem cells, our team seeks to discover the biochemical vulnerabilities of cancer stem cells and how to eliminate them.

Functions of Tumor Microenvironment and Key Signaling Changes

All organs have a unique microenvironment, specialized for function, and with cancer we have to understand the communication between a tumor and the microenvironment.

Cell behaviors change based on the microenvironment in which they live. The microenvironment can cause cancer cells to grow rather than allowing the immune system to fight the cancer. By observing both normal and cancer cells,we gain a greater understanding of the immune system and how we can alter this behavior.

This signaling or communication within the microenvironment is key to targeted therapy because signaling molecules are activated by the specific tumor. We then can activate the immune system to work against the tumor by preventing the signaling. By influencing this signaling behavior, we can stop cancer growth.


Scientific Goals Lead to New Treatments

Signaling and Tumor Microenvironment Program members generate new knowledge that leads to a deeper understanding of cellular and extracellular factors regulating tumor initiation, expansion, invasion and metastasis, with the goal of applying this knowledge to improve cancer prevention, diagnosis and treatment.

Investigators whose main focus is the microenvironment use multiple approaches to understand the interaction of tumor cells with cellular and extracellular components of the microenvironment.


Program-wide Mentoring Focus for Education and Training

Across the entire Signaling and Tumor Microenvironment Program, leadership has implemented a mentoring program to provide input on grant submissions and optimal research engagements and to help identify career development opportunities. This collaborative approach provides a more conducive environment to advancing cancer biology discovery. The program has a long-standing commitment to education for graduate and post-doctoral training. Home to the NCI-funded Cancer Biology Training Program, our members continue to significantly impact the education and training of the next generation of cancer biology investigators.

Meet our Leaders

pascadimagliano_marina4x5

Marina Pasca di Magliano, PhD

Marina Pasca di Magliano, PhD
Maud T Lane Professor of Surgical Immunology
Professor of Surgery
Professor of Cell and Developmental Biology
Co-Leader Signaling and Tumor Microenvironment Program
Co-Director of the Rogel and Blondy Center for Pancreatic Cancer
Rogel Cancer Center
Medical School
Yatrik M. Shah

Yatrik M Shah

Horace W Davenport Legacy Professor of Physiology
Professor of Molecular and Integrative Physiology
Professor of Internal Medicine and Associate Director Academic Programs, Cancer Biology Graduate Program
Medical School
zou weiping

Weiping Zou

Charles B de Nancrede Research Professor of Surgery
Professor of Surgery
Professor of Pathology
Medical School

Work With Us

Privileges of research members include priority access to Center‐funded Shared Resources and other facilities at favorable rates, clinical research support for protocol development and management, and members‐only funding opportunities. Other opportunities may include participation in shared‐interest affinity groups, leadership roles, and support in cancer career development.

NOTE: Available to University of Michigan faculty only
Open and complete the application.

News & Stories

clear see through pill floating with other little pills behind in blue teal pink background
Health Lab

Stopping Ewing sarcoma relapses where they start

Research on stopping Ewing sarcoma relapses through Michigan Medicine.
yellow black purple red cell in middle mostly black
Health Lab

Study sheds light on how early pancreas lesions become cancerous

Why many precursor lesions never develop into pancreatic cancer, according to findings from Michigan Medicine.
green pink close up on microscope
Health Lab

New mouse model for liposarcoma can help uncover new therapies

There has been little progress in understanding and treating liposarcoma due to its rarity and lack of research resources. In a new study, University of Michigan researchers have developed a novel mouse model that mirrors the disease in humans.
woman in white coat talking in lab with lab glasses on
Health Lab

Expanding brain tumor research  

Maria Castro, Ph.D, of Michigan Medicine, received a prestigious $4.5M NIH grant that will help advance the understanding about deadly tumors and provide a path for developing new treatments.
lots of the same fish swimming inside blue teal water
Health Lab

Additional testing can improve kidney cancer diagnosis

Michigan Medicine findings suggest further investigation of FISH-negative tests for renal cell carcinoma could lead to more accurate diagnosis.
blue and white pill being broken and dots falling out in middle
Health Lab

Researchers find a targeted approach to shut down prostate cancer growth

Study shows a novel compound that degrades key proteins found in prostate cancer cells blocks oncogenic androgen receptor signaling.